News The curious case of Mylotarg: Pfizer's leukaemia drug set to... Mylotarg backed by advisers after withdrawal in 2010.
News Novartis CAR-T safety in FDA spotlight FDA advisers are set to make recommendations on Novartis’ groundbreaking CAR-T therapy CTL019 tomorrow – and are set to focus on safety concerns in the decisive meeting.
News Pfizer facing NICE showdown over leukaemia drug Pfizer locks horns with NICE following EU approval.
News NICE green light a win for Lilly in RA market RA drug backed after manufacturer offered discount.
News Kisqali set for approval - but likely to hit same NICE obsta... Concerns that NICE will reject Kisqali like it did Ibrance.
News Australia starts probe into AI infiltration of Medicare The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.